The concerning increase in respiratory infections that are resistant to multiple drugs has led to a growing interest in bacteriophage therapy as a potential alternative to conventional antibiotics. Effective phage delivery to the lungs, however, presents several formulation and stability issues, particularly for inhalation-based methods. This review highlights current developments in the creation of dry powder formulations that can be inhaled for pulmonary phage therapy, with a focus on encapsulation methods based on nanoparticles, such as solid lipid nanoparticles (SLNs) and polymer-based nanoparticles. These carriers enhance the aerodynamic characteristics of phages, making them suitable for deep lung deposition, while also protecting them during processing and storage. Several drying methods have been investigated to create powders with optimal morphologies, porosity, and dispersibility, including spray drying and spray freeze drying. The review also emphasizes how the phage morphotype affects stability, especially when nebulization stress is present. Furthermore, the advantages of nanoparticle matrices are confirmed by the reduced viability loss (usually< 0.5 log PFU) of encapsulated phages. Standardizing production processes, scaling up, and ensuring regulatory compliance remain challenging despite encouraging preclinical results. The combination of phage therapy with nanotechnology creates new avenues for the utilization of inhalable delivery methods to treat multidrug-resistant pulmonary infections. To translate these novel formulations from preclinical development to clinical application, sustained multidisciplinary collaboration across pharmaceutical sciences, microbiology, and clinical pharmacology is essential.
Background: Silver nanoparticles (AgNPs) show promises as antimicrobial biomaterials with use for combating multidrug-resistant microorganisms, and they are widely used in healthcare, medicine, and food industries. However, traditional physicochemical synthesis methods often require harsh conditions and toxic reagents, generating harmful waste. The synthesis of AgNPs using plant-derived bioactive compounds offers an eco-friendly alternative to conventional methods. Methods: In this study, a bio-green approach was employed to synthesize AgNPs using ethanolic extracts from Antigonon leptopus leaves (EXT-AL). The synthesis was optimized under different pH conditions (5.5, 8.0, 10.0) and EXT-AL concentrations (10–200 μg/mL). Antibacterial activity was evaluated against Escherichia coli and Staphylococcus aureus, and cytotoxicity was assessed in HeLa, CaCo-2, T731-GFP, and HaCaT cell lines. Results: UV-Vis spectroscopy confirmed nanoparticle formation, with a surface plasmon resonance peak at 410 nm. Alkaline conditions (pH 10.0) favored the formation of smaller, spherical AgNPs. Characterization by DLS, TEM, and AFM revealed uniform nanoparticles with a hydrodynamic diameter of 93.48 ± 1.88 nm and a zeta potential of −37.80 ± 1.28 mV. The AgNPs remained stable in Milli-Q water but tended to aggregate in PBS, DMEM, and MHB media. Antibacterial assays demonstrated significant bactericidal activity against Escherichia coli and Staphylococcus aureus at 3.9 μg/mL (Ag⁺ equivalent). Cytotoxicity tests showed no toxicity to HeLa, T731-GFP, CaCo-2, or HaCaT cells at concentrations ≥ 7.8 μg/mL after 24 h. Conclusions: These findings highlight Antigonon leptopus extract as a sustainable and cost-effective resource for AgNPs synthesis, with strong antimicrobial properties and potential biomedical applications.
Bacterial infections remain among the top ten major public health concerns, contributing to a high number incidence of disease and mortality worldwide. This issue has been exacerbated by the rise of multidrug-resistant bacteria (MDRB). Consequently, it is crucial to develop novel antimicrobial strategies, including the use of functional nanoparticles. Gold nanoparticles (GNPs) have emerged as promising candidates due to their unique optical properties, particularly their ability to efficiently convert absorbed light into heat through the photothermal (PT) effect, which can be harnessed for bacteria eradication. In this study, gold nanoshells (GNSs) were synthesized and proposed as photothermal devices to bacteria clearance via PT. First, chitosan was modified with 3-mercaptopropionic acid to introduce sulfur groups, facilitating gold deposition onto chitosan nanoparticle surface. Thiolated chitosan nanoparticles (TCNPs), with a size of 178 nm and spherical morphology were synthesized using the ionic gelation method. The gold shell was subsequently formed via a seed-mediated method, wherein gold seeds were adsorbed onto TCNPs and further grown to form the shell. The resulting TCNP@Au exhibited a photothermal conversion efficiency of 31%, making them a promising photothermal agent for bacterial clearance. Notably, the viability of Escherichia coli was significantly reduced in the presence of TCNP@Au and was almost eradicated upon PT treatment, with viability dropping to 0.3 %. In contrast, TCNP@Au were non-toxic for Staphylococcus aureus. Interestingly, S. aureus exhibited a reduced susceptibility to the PT effect, maintaining a viability of 76 % after the laser irradiation treatment. Despite these results, TCNP@Au demonstrated favorable photothermal properties, presenting a novel nanoplatform for antibacterial applications, particularly against Gram-negative bacteria. However, further investigation is required to optimize the PT-based strategies against Gram-positive bacteria, such as S. aureus.
Background/Objectives: Bacterial infections remain among the top ten major public health concerns, contributing to a high number of incidences of disease and mortality worldwide, exacerbated by the rise of multidrug-resistant bacteria (MDRB). Consequently, it is crucial to develop novel antimicrobial strategies, including the use of functional nanoparticles. Gold nanoparticles (GNPs) have emerged as promising candidates due to their unique optical properties, particularly their ability to efficiently convert absorbed light into heat through the photothermal (PT) effect, which can be harnessed for bacteria eradication. Methods: Chitosan was modified with 3-mercaptopropionic acid to introduce sulfur groups, facilitating gold deposition onto chitosan nanoparticle (TCNPs) surface. The gold shell was subsequently formed via a seed-mediated method, wherein gold seeds were adsorbed onto TCNPs and further grown to form the shell. Photothermal effect on the bacterial viability was evaluated. Results: TCNPs with a size of 178 nm and spherical morphology were obtained. After the gold shell (TCNP@Au) exhibited a photothermal conversion efficiency of 31%, making them a promising photothermal agent for bacterial clearance. Notably, the viability of Escherichia coli was significantly reduced in the presence of TCNP@Au and was almost eradicated upon PT treatment. In contrast, TCNP@Aus were non-toxic for Staphylococcus aureus. Conclusions: TCNP@Au demonstrated favorable photothermal properties, presenting a novel nanoplatform for antibacterial applications, particularly against Gram-negative bacteria. However, further investigation is required to optimize the PT-based strategies against Gram-positive bacteria, such as S. aureus.
Background/Objectives: The quest for effective therapeutic alternatives for infec-tions caused by multidrug-resistant (MDR) bacteria remains a major global health priority. In this context, bacteriophage therapy has re-emerged as a promising strate-gy due to its high host specificity and ability to infect and lyse targeted bacterial strains. However, clinical translation is limited by biological and technological chal-lenges, including phage instability and rapid inactivation after administration. Algi-nate- and chitosan-based polymeric nanomatrices offer a practical way to address these limitations. Properly engineered nanoparticles can improve phage stability, protect against environmental stressors, reduce inactivation, and enable localized, controlled release at the infection site. Methods: A polysaccharide-based nanocarrier composed of hydrophobically modified alginate (mAlg) and chitosan was developed. Encapsulation of bacteriophage vB_Eco_K-02 within mAlg-Cs nanoparticles was achieved by ultrasonication-assisted polyelectrolyte complexation. Particle size, ζP, and morphology were evaluated, and phage encapsulation efficiency and antibacte-rial activity were assessed in vitro. Results: The mAlg-Cs formulation at a 1:0.625 mass ratio yielded nanoparticles with the most favorable physicochemical properties, including improved size distribution, high colloidal stability, and regular morphology. vB_Eco_K-02-loaded NPs (mAlg-Cs-Phg) achieved a high encapsulation efficiency (99 %) and preserved lytic activity after formulation, resulting in strong inhibition of E. coli growth in kinetic assays. Conclusions: mAlg-Cs nanoparticles provide an effi-cient platform for encapsulating vB_Eco_K-02 while preserving phage infectivity and enabling effective antibacterial activity. This nanosystem represents a promising strategy to enhance phage delivery for the treatment of bacterial infection.